3-(3-(2-Methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide

Catalog No. :
ACRVYP138
CAS No. :
1415251-36-3
Molecular Formula :
C27H28N2O3S
Molecular Weight :
460.60

IUPAC Name:3-(3-(2-methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide

3-(3-(2-Methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$170.00Login to see priceInquiryInquiry
250mg98%$254.00Login to see priceInquiryInquiry
1g98%$636.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-(2-Methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide
IUPAC Name3-(3-(2-methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide
Molecular FormulaC27H28N2O3S
Molecular Weight460.60
SMILESO=C(NCCCCC1=CC=CC=C1)C2=CC=CC(C(N3C4=CC=CC=C4OC)SCC3=O)=C2
InChI KeyBOSNKHFAOWELSW-UHFFFAOYSA-N
Synonym3-(3-(2-Methoxyphenyl)-4-oxothiazolidin-2-yl)-N-(4-phenylbutyl)benzamide
CAS No.1415251-36-3
PubChem CID134820567

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRVYP138 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDZMA492 route compound structure diagram
    ACDZMA49213214-66-9 In Stock
  4. Then
  5. ACRVYP138 route product structure diagram
    ACRVYP1381415251-36-3
Inquiry

2. ACRVYP138 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDZMA492 route compound structure diagram
    ACDZMA49213214-66-9 In Stock
  4. Then
  5. ACRVYP138 route product structure diagram
    ACRVYP1381415251-36-3
Inquiry

Comments (0)